ImmunologybioRxivPreprint
A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity
A. Nicolas, G. Sannier, M. Dube…·D. E. Kaufmann
This study shows that a longer interval between SARS-CoV-2 mRNA vaccine doses enhances B cell responses but has minimal impact on T cell immunity.
DOI 10.1101/2022.08.03.502672